Postoperative Pain Control in Total Shoulder Arthroplasty

Completed · Phase 4

Conditions studied: Total Shoulder Arthroplasty

In brief

A double blind, prospective, randomized trial to evaluate postoperative pain, narcotic use, patient satisfaction, and function among shoulder arthroplasty patients receiving interscalene block with and without the addition of liposomal bupivacaine.

Key facts

Study ID

NCT05068960

Run by

Scripps Clinic

People needed

100

Starts

2021-03-01

Expected to finish

2025-02-01

Last updated by the study team

2025-03-21

Who can join

Age: 50 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients undergoing primary shoulder arthroplasty or reverse shoulder arthroplasty

You may not qualify if…

• Patients under the age of 50 years
• Patients over the age of 85
• Patients undergoing a revision shoulder procedure
• Documented drug or alcohol abuse
• Active narcotic use within 3 months prior to surgery
• Neurological deficit
• Allergy to amide anesthetics
• Oxycodone intolerance
• Unable to take Celebrex
• Enrollment in another clinical trial
• Comorbidity that is contraindicated with the administration of an interscalene block
• Cognitive or mental health status that interferes with study

Where it is running

• Scripps Clinic — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.